1. Institute of Medicine of the National Academies. Rare diseases and orphan products. accelerating research and development. The National Academies Press (2010)
2. European Commission. Improving access to orphan medicines for all affected EU citizens. Available at: http://ec.europa.eu/pharmaphorum/docs/pricing_orphans_en.pdf
3. EUROSDIS. Rare diseases: Understanding this public health priority (2005). Available at: http://www.eurordis.org/publication/rare-diseases-understanding-public-health-priority
4. Fischer, A., Borensztein, P., Roussel, C.: The European rare diseases therapeutic initiative. PLoS Med. 2(9), e243 (2005)
5. Commission of the European Communities. Communication from the Commission to the European Parliament, the Council, the European Economic and Social Committee and the Committee of the Regions on Rare Diseases: Europe’s challenges Brussels, 11.11.2008. Available at: http://ec.europa.eu/health/ph_threats/non_com/docs/rare_com_en.pdf